Literature DB >> 7866734

Barrett's esophagus.

S J Spechler1.   

Abstract

Barrett's esophagus is the condition wherein columnar epithelium replaces squamous epithelium in the esophagus. The condition is named for the late Mr Normal Barrett, an English surgeon whose most renowned publication, ironically, is a treatise contending that the esophagus cannot be lined by columnar epithelium. The eponym is used commonly despite Mr Barrett's mistaken contention, although some European authors still prefer to call the condition "endobrachyesophagus." Barrett's esophagus appears to be a sequela of gastroesophageal reflux disease (GERD), and it is the major known risk factor for esophageal adenocarcinoma. Barrett's esophagus is usually discovered during endoscopic evaluation of patients who have symptoms caused by GERD or esophageal cancer. Consequently, data on the clinical features of Barrett's esophagus are derived primarily from studies on symptomatic patients in whom the condition was recognized endoscopically. Recent investigations suggest that more than 90% of cases of Barrett's esophagus in the general population are not recognized by physicians, and many of these unrecognized patients have few or no symptoms of GERD. It is important to appreciate, therefore, that conclusions drawn from studies on patients with clinically apparent disease are not necessarily applicable to the "silent majority" of individuals with Barrett's esophagus.

Entities:  

Mesh:

Year:  1994        PMID: 7866734

Source DB:  PubMed          Journal:  Gastroenterologist        ISSN: 1065-2477


  7 in total

Review 1.  Narrow band imaging in gastroesophageal reflux disease and Barrett's esophagus.

Authors:  Mitchell M Lee; Robert Enns
Journal:  Can J Gastroenterol       Date:  2009-02       Impact factor: 3.522

2.  Aspirin protects against Barrett's esophagus in a multivariate logistic regression analysis.

Authors:  Zehra B Omer; Ashwin N Ananthakrishnan; Kevin J Nattinger; Elisabeth B Cole; Jesse J Lin; Chung Yin Kong; Chin Hur
Journal:  Clin Gastroenterol Hepatol       Date:  2012-03-15       Impact factor: 11.382

3.  Assessing the conditions for in vivo electrical virtual biopsies in Barrett's oesophagus.

Authors:  C A González-Correa; B H Brown; R H Smallwood; N Kalia; C J Stoddard; T J Stephenson; S J Haggie; D N Slater; K D Bardhan
Journal:  Med Biol Eng Comput       Date:  2000-07       Impact factor: 2.602

4.  Use of a novel monoclonal antibody in diagnosis of Barrett's esophagus.

Authors:  L H Griffel; P S Amenta; K M Das
Journal:  Dig Dis Sci       Date:  2000-01       Impact factor: 3.199

5.  Genetic alterations in Barrett esophagus and adenocarcinomas of the esophagus and esophagogastric junction region.

Authors:  T T Wu; T Watanabe; R Heitmiller; M Zahurak; A A Forastiere; S R Hamilton
Journal:  Am J Pathol       Date:  1998-07       Impact factor: 4.307

6.  Surveillance in Barrett esophagus.

Authors:  C Gindea; R Birla; P Hoara; A Caragui; S Constantinoiu
Journal:  J Med Life       Date:  2014

7.  Multi-colour FISH in oesophageal adenocarcinoma-predictors of prognosis independent of stage and grade.

Authors:  C-I Geppert; P Rümmele; M Sarbia; R Langer; M Feith; L Morrison; E Pestova; R Schneider-Stock; A Hartmann; T T Rau
Journal:  Br J Cancer       Date:  2014-05-22       Impact factor: 7.640

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.